Last Close
139.83 $
Jul 7, 26
Market Cap
7.9 B $
Q1 2026 (TTM)
52-Week Range
%+12.4
%46.3
-0.38
-0.40
%-18.8
-%40.3
1M
+14.3%
3M
+21.3%
6M
-18.8%
YTD
-14.7%
1Y
+12.4%
3Y
-1.2%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
RGEN last closed at 139.83 $ (Jul 7, 26). Price data is refreshed after every trading day.
Repligen Corporation trades at a trailing-twelve-month P/E of 154.16. See the comparison tables on the Peers tab for the industry context.
Repligen Corporation (RGEN) has a market capitalization of approximately 7.9 B $ as of the latest reported period.
Key peers of Repligen Corporation include Fisher & Paykel Healthcare Corporation Ltd, Resmed Inc, Ansell Ltd, EssilorLuxottica S. A.. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.